Multiple reports say President Donald Trump plans to fire FDA Commissioner Marty Makary, though the decision is not finalized and could change. The alleged move would end Makary’s roughly yearlong tenure, a period marked by policy disputes and high-profile controversy over review consistency and public-health decisions. The Wall Street Journal reports the White House is considering the change as Makary faces criticism spanning vaccine and regulatory policy, including earlier backlash tied to discussions around vaccine studies and product approvals. The potential leadership shift comes amid broader scrutiny of FDA turnover and expert capacity, with downstream implications for how sponsors interpret regulatory engagement during active review cycles.